Acknowledgements This work was supported by NANJING ANJI BIOTECHNOLOGY Co
Off-Label Use in Men Although interest in PT-141 for men continues to grow, the FDA has not approved it for male sexual dysfunction
#Research #InternalMedicine #MedEd To view or add a comment, sign in Metabolic Medicine & Cardiovascular Health Metabolic treatments have pivoted heavily toward disease reversal rather than just blood-sugar management, with popular GLP-1 medications significantly lowering the risk of heart failure hospitalizations
I give all those statistics and epidemiology because this study was designed to ensure that it didnt over enroll for men, and not and have the purposeful inclusion of women to be well-represented, and so they did cap at 70% enrollment for men
Di Angelantonio, E., Bhupathiraju, S
Abstract The transforming growth factor- (TGF-)/Suppressor of Mothers against Decapentaplegic (Smad) signaling pathway plays an important role in the pathogenesis and progression of liver fibrosis